Zobrazeno 1 - 10
of 22 928
pro vyhledávání: '"ABIRATERONE acetate"'
Autor:
Akbel, Erten1 (AUTHOR) erten.akbel@usak.edu.tr
Publikováno v:
Separations (2297-8739). Oct2024, Vol. 11 Issue 10, p290. 15p.
Publikováno v:
European Journal of Cardiovascular Medicine. 2024, Vol. 14 Issue 2, p194-197. 4p.
Autor:
Chamorey, Emmanuel1 (AUTHOR) jocelyn.gal@nice.unicancer.fr, Pujalte-Martin, Marc2 (AUTHOR), Ferrero, Jean-Marc2 (AUTHOR), Mahammedi, Hakim3 (AUTHOR), Gravis, Gwenaelle4 (AUTHOR), Roubaud, Guilhem5 (AUTHOR), Beuzeboc, Philippe6 (AUTHOR), Largillier, Remy7 (AUTHOR), Borchiellini, Delphine2,8 (AUTHOR), Linassier, Claude9 (AUTHOR), Bouges, Hélène10 (AUTHOR), Etienne-Grimaldi, Marie-Christine10 (AUTHOR), Schiappa, Renaud1 (AUTHOR), Gal, Jocelyn1 (AUTHOR), Milano, Gérard10 (AUTHOR) gerard.milano@nice.unicancer.fr
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6058. 11p.
Autor:
Detassis, Simone1,2 (AUTHOR) simone.detassis@optoi.com, Precazzini, Francesca1,3 (AUTHOR), Grasso, Margherita1,4 (AUTHOR), Del Vescovo, Valerio1,5 (AUTHOR), Maines, Francesca6 (AUTHOR), Caffo, Orazio6 (AUTHOR), Campomenosi, Paola7 (AUTHOR), Denti, Michela A.1 (AUTHOR) michela.denti@unitn.it
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5573. 13p.
Autor:
Fukuokaya W; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan. wfukuokaya@gmail.com., Mori K; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Akazawa K; Department of Medical Informatics, Niigata University Medical and Dental Hospital; 1-754 Asahimachi-dori, Chuo-ku, Niigata, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep; Vol. 27 (3), pp. 444-450. Date of Electronic Publication: 2023 Jul 18.
Autor:
Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy., Lee-Ying R; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Rossetti S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., Davidsohn M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Oliveira TM; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Malgeri A; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy., Modesti M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ravi P; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Pignata S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102185. Date of Electronic Publication: 2024 Aug 09.
Autor:
Sudhakaran G; Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Tamil Nadu, India. Electronic address: gokuls.smc@saveetha.com.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102152. Date of Electronic Publication: 2024 Jul 03.
Autor:
Lam B; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Rodgers JE; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Muluneh B; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Proco D; GlaxoSmithKline, Research Triangle Park, Durham, North Carolina, USA., Whang YE; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Morgan KP; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Publikováno v:
The Annals of pharmacotherapy [Ann Pharmacother] 2024 Oct; Vol. 58 (10), pp. 994-1002. Date of Electronic Publication: 2024 Feb 12.
Autor:
Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France. Electronic address: g.roubaud@bordeaux.unicancer.fr., Attard G; University College London Cancer Institute, London, UK., Boegemann M; Department of Urology, Muenster University Hospital, Muenster, Germany; Westgerman Cancer Center, Münster, Germany., Olmos D; Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain., Trevisan M; Janssen EMEA, Geneva, Switzerland., Antoni L; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Pascoe K; Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Capone C; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Van Sanden S; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Hashim M; Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Palmer S; Centre for Health Economics, University of York, York, UK., Chi K; BC Cancer and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 209, pp. 114183. Date of Electronic Publication: 2024 Jun 17.
Autor:
Bahl A; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation, Bristol, UK., Sodatonou H; Astellas Pharma Europe Ltd., Surrey, UK. hanna.sodatonou@iqvia.com., Snjider R; Astellas Pharma Europe Ltd., Surrey, UK., Chilelli A; Astellas Pharma Europe Ltd., Surrey, UK., Pranzo A; Astellas Pharma Europe Ltd., Surrey, UK., Martins K; Astellas Pharma Europe Ltd., Surrey, UK., Merseburger A; University Hospital Schleswig-Holstein, Lübeck, Germany., Rozario N; Astellas Pharma Europe Ltd., Surrey, UK., Crawley D; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Translational Oncology Urology Research Group, King's College London, London, UK.
Publikováno v:
World journal of urology [World J Urol] 2024 Oct 18; Vol. 42 (1), pp. 584. Date of Electronic Publication: 2024 Oct 18.